Cerebral Embolic Protection Devices for TAVI Market

Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
Cerebral Embolic Protection Devices for TAVI Market contains market size and forecasts of Cerebral Embolic Protection Devices for TAVI in global, including the following market information:
Global Cerebral Embolic Protection Devices for TAVI Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cerebral Embolic Protection Devices for TAVI Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Cerebral Embolic Protection Devices for TAVI companies in 2021 (%)
The global Cerebral Embolic Protection Devices for TAVI market was valued at 54 million in 2021 and is projected to reach US$ 253.1 million by 2028, at a CAGR of 24.8% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Total Artery Coverage Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cerebral Embolic Protection Devices for TAVI include Boston Scientific (Claret Medical), Venus Medtech (Keystone Heart), Transverse Medical, Innovative Cardiovascular Solutions, Protembis GmbH, Filterlex Medical and Emboline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cerebral Embolic Protection Devices for TAVI manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cerebral Embolic Protection Devices for TAVI Market, by Artery Coverage Cover, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Cerebral Embolic Protection Devices for TAVI Market Segment Percentages, by Artery Coverage Cover, 2021 (%)
Total Artery Coverage
Non-total Artery Coverage
Global Cerebral Embolic Protection Devices for TAVI Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Cerebral Embolic Protection Devices for TAVI Market Segment Percentages, by Application, 2021 (%)
Hopsital
Others
Global Cerebral Embolic Protection Devices for TAVI Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Cerebral Embolic Protection Devices for TAVI Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cerebral Embolic Protection Devices for TAVI revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cerebral Embolic Protection Devices for TAVI revenues share in global market, 2021 (%)
Key companies Cerebral Embolic Protection Devices for TAVI sales in global market, 2017-2022 (Estimated), (Units)
Key companies Cerebral Embolic Protection Devices for TAVI sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline